Citation Study Reveals Moscow As Leader In Research Paper Publishing

RANK CITY 1991 PAPERS PERCENT CHANGE 1981 TO 1991 1 Moscow 14,541 + 7.3 2 London 14,051 +11.4 3 Boston/Cambridge, Mass. 12,480 +18.4 4 Tokyo 11,582 +41.1 5 New York 8,551 + 6.8 6 Paris 7,964 +11.4 7 Los Angeles 6,601 +13.6 8 Bethesda, Md. 6,233 +13.3 9 Philadelphia 6,183 +19.0 10 Osaka, Japan 5,408 +57.3 11 Washington, D.C. 5,388 + 1.4 12 Chicago 5,174 - 0.9 13 Baltimore 4,933 +44.7 14 Houston 4,911 +27.9 15 San Diego/La Jolla, Calif 4,740 +32.3 16 Stanford/Palo Alto, Calif 4,201 +16.3 17 Seat

| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

SOURCE: Science Watch/ISI's Science Citation Index, 1991

That Moscow has remained so strong in its research paper output-- at least through the end of 1991--is perhaps attributable to the strict centralization of scientific facilities in the Soviet Union. Although St. Petersburg may run a distant second, Moscow is where the vast preponderance of Russian science is done. Note in the accompanying table that no other Russian or former Soviet Union cities made the top 25, while the United States had 14 cities, the United Kingdom and Japan each had three, and Canada had two cities on the list.

In its analysis, Science Watch also compared each of the 25 cities' scientific publication output with its 1981 record. It found that the Japanese city of Osaka, while ranking 10th on the 1991 list, had made the largest gain among the leading cities in productivity during the 1980s--its total of 5,408 papers ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies